GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Hunan Warrant Pharmaceutical Co 688799.SS · CNY

Health Care · Shanghai · 🇨🇳 China

Compare

51.29

+9.13%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.52bn

FY2015FY2025

Net income

CN¥241.5m

FY2015FY2025

Free cash flow

−CN¥220.1m

FY2015FY2025

Shareholders' equity

CN¥2.04bn

FY2015FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015
RevenueCN¥1.52bnCN¥1.41bnCN¥1.43bnCN¥1.29bnCN¥1.15bnCN¥950.6mCN¥824.6mCN¥613.2mCN¥374.9mCN¥255.6m
Research and developmentCN¥129.9mCN¥161.0mCN¥103.2mCN¥88.7mCN¥70.1mCN¥63.7mCN¥45.4mCN¥25.6mCN¥15.2mCN¥16.3m
Operating incomeCN¥245.1mCN¥161.8mCN¥237.1mCN¥196.0mCN¥181.9mCN¥160.9mCN¥127.7mCN¥104.2mCN¥56.0mCN¥19.2m
Net incomeCN¥241.5mCN¥164.3mCN¥211.3mCN¥182.8mCN¥160.8mCN¥145.0mCN¥116.0mCN¥88.5mCN¥59.8mCN¥18.8m
Diluted earnings per share1.841.241.591.413.001.471.670.670.460.14

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015
Total assetsCN¥3.05bnCN¥2.46bnCN¥2.18bnCN¥2.01bnCN¥1.80bnCN¥921.1mCN¥851.4mCN¥732.0mCN¥626.3mCN¥390.0m
Cash and short-term investments—CN¥360.7mCN¥744.3mCN¥516.3mCN¥753.4mCN¥79.0mCN¥70.9mCN¥19.6mCN¥39.8mCN¥6.8m
Total liabilitiesCN¥1.01bnCN¥637.1mCN¥408.7mCN¥350.3mCN¥318.1mCN¥258.1mCN¥298.3mCN¥273.8mCN¥242.5mCN¥103.3m
DebtCN¥497.6mCN¥117.7mCN¥17.1mCN¥13.1mCN¥6.8mCN¥11.8mCN¥19.8mCN¥500,000CN¥40.0mCN¥20.0m
Shareholders' equityCN¥2.04bnCN¥1.80bnCN¥1.72bnCN¥1.60bnCN¥1.48bnCN¥663.0mCN¥553.2mCN¥458.2mCN¥383.8mCN¥286.7m
Shares outstanding131m132m133m130m54m99m69m131m131m131m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2015
Cash from operationsCN¥300.2mCN¥142.2mCN¥214.4mCN¥155.6mCN¥114.7mCN¥104.7mCN¥116.7mCN¥64.8mCN¥56.2mCN¥11.3m
Capital spending−CN¥520.3m−CN¥233.9m−CN¥105.8m−CN¥131.8m−CN¥92.1m−CN¥53.7m−CN¥24.3m−CN¥35.4m−CN¥37.6m−CN¥107.6m
Free cash flow−CN¥220.1m−CN¥91.6mCN¥108.7mCN¥23.8mCN¥22.6mCN¥50.9mCN¥92.3mCN¥29.4mCN¥18.6m−CN¥96.3m
Dividends paid−CN¥63.0m−CN¥86.3m−CN¥84.4m−CN¥65.7m—−CN¥35.1m−CN¥35.2m−CN¥721,848−CN¥2.1m−CN¥1.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥336.1mCN¥324.5mCN¥429.8mCN¥372.1mCN¥377.5mCN¥336.2mCN¥343.6mCN¥330.7m
Operating incomeCN¥46.7mCN¥35.8mCN¥35.2mCN¥140.6mCN¥29.3mCN¥46.6m−CN¥1.8mCN¥42.2m
Net incomeCN¥37.7mCN¥26.9mCN¥34.3mCN¥136.0mCN¥29.9mCN¥41.2mCN¥5.9mCN¥45.6m
Diluted earnings per share0.290.200.261.040.230.310.040.35
Cash from operations———CN¥124.0mCN¥40.0mCN¥41.0m—CN¥21.0m
Capital spending−CN¥110.0m−CN¥188.0m−CN¥180.0m−CN¥125.0m−CN¥114.0m−CN¥99.0m−CN¥122.0m−CN¥32.0m
Free cash flow———−CN¥1.0m−CN¥74.0m−CN¥58.0m—−CN¥11.0m
Total assetsCN¥3.44bnCN¥3.24bnCN¥3.05bnCN¥2.78bnCN¥2.53bnCN¥2.47bnCN¥2.46bnCN¥2.38bn
Cash and short-term investments———CN¥295.9mCN¥195.4mCN¥304.5mCN¥360.7mCN¥350.1m
DebtCN¥772.0mCN¥672.0mCN¥497.6mCN¥229,465CN¥235.8mCN¥137.1mCN¥117.7mCN¥91.9m
Shareholders' equityCN¥2.12bnCN¥2.08bnCN¥2.04bnCN¥1.99bnCN¥1.84bnCN¥1.85bnCN¥1.80bnCN¥1.88bn

Financial ratios

Data as of 13 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017FY2015
Operating margin16.2%11.4%16.1%15.1%15.7%17.3%———
Net margin15.9%11.6%14.7%14.1%14.0%15.3%———
Return on equity11.8%9.1%12.3%11.4%10.9%21.9%———
Return on assets7.9%6.7%9.7%9.1%8.9%15.7%———
Free cash flow yield13.0%5.9%5.0%4.6%8.0%3.3%———
Revenue growth7.3%-1.4%10.8%12.7%20.6%15.3%———
Earnings growth47.0%-22.2%15.6%13.7%10.8%25.0%———
Current ratio2.86x3.42x4.01x4.23x4.65x1.89x———
Debt to equity0.24x0.07x0.01x———0.00x0.10x0.01x
Equity ratio66.9%73.3%79.2%79.5%82.3%72.0%———
Interest coverage379.30x9395.87x1915.29x1195.85x1082.17x3229.60x———
R&D as a share of sales8.6%11.4%7.2%6.9%6.1%6.7%———
Buybacks as a share of market value0.7%0.4%-2.0%-142.4%45.7%-42.4%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue5.4%9.8%19.9%
Operating income7.7%8.8%24.1%
Net income9.7%10.7%24.1%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin13.9%14.9%15.3%15.1%
Net margin13.9%14.1%14.3%14.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021
Price to earnings25.924.121.916.29.8
Price to sales4.12.83.22.31.4

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 1 Jul 2026.

FY2026FY2025FY2024FY2023FY2022
Paid in the year0.1790.4290.6430.6430.50
  • 7-for-5 split · 29 May 2025

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.